Earn Continuing Medical Education Online

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

CME
Outcomes of Strabismus Surgery for Esotropia in Children With Down Syndrome Compared With Matched Controls
July 1, 2012
Purpose: Strabismus surgery dosages used in children with various neurodevelopmental disorders have been the subject of controversy. Few data have been reported regarding surgical results in… More »
Credit Type(s): CME | Credit: 1

The Role of Nutritionals in the Aging Eye
June 22, 2012
With approximately 1.75 million people affected by AMD and that number expected to nearly double by 2020, physicians will begin to see an increasing number of patients requesting interventions that… More »
This Ocular Surgery News supplement is produced by SLACK Incorporated and sponsored by Bausch + Lomb

CME
June 2012: Evolution of Psychoeducation
June 20, 2012
Psychoeducation in patients with serious mental illness has been shown to be effective, yet is often absent from most clinical practices and settings. Although we might think that we are… More »
Vindico Medical Education and Psychiatric Annals
Credit Type(s): CME | Credit: 3

CMEVIDEO
On the Scene at ADA 2012: Interview with Bernard Zinman, MD – Comparing short- and long-acting GLP-1 agonists
June 13, 2012
The incretin-based therapies, including GLP-1 receptor agonists and DPP-4 inhibitors, have been shown to offer a number of benefits over other treatments for type 2 diabetes, including reduction of… More »
This activity is supported by an educational grant from Amylin Pharmaceuticals, Inc.
Credit Type(s): CME | Credit: 0.25

CMEVIDEO
On the Scene at ADA 2012: Interview with Jack L. Leahy, MD – GLP-1 agonists as monotherapy and in combination with insulin
June 13, 2012
The incretin-based therapies, including GLP-1 receptor agonists and DPP-4 inhibitors, have been shown to offer a number of beneficial cardiovascular and lipid effects in addition to enhancing… More »
This activity is supported by an educational grant from Amylin Pharmaceuticals, Inc.
Credit Type(s): CME | Credit: 0.25

CMEVIDEO
On the Scene at ADA 2012: Interview with Michael H. Davidson, MD – Cardiovascular implications of glycemic control and therapy
June 13, 2012
The incretin-based therapies, including GLP-1 receptor agonists and DPP-4 inhibitors, have been shown to offer a number of beneficial cardiovascular and lipid effects in addition to enhancing… More »
This activity is supported by an educational grant from Amylin Pharmaceuticals, Inc.
Credit Type(s): CME | Credit: 0.25

CMEVIDEO
On the Scene at ADA 2012: Interview with Robert R. Henry, MD – Reviewing the latest clinical trials of incretin-based therapy
June 13, 2012
The incretin-based therapies, including GLP-1 receptor agonists and DPP-4 inhibitors, have been shown to offer a number of beneficial cardiovascular and lipid effects in addition to enhancing… More »
This activity is supported by an educational grant from Amylin Pharmaceuticals, Inc.
Credit Type(s): CME | Credit: 0.25

CMEVIDEO
On the Scene at ADA 2012: Interview with Bernard Zinman, MD - Comparing short- and long-acting GLP-1 agonists
June 13, 2012
The incretin-based therapies, including GLP-1 receptor agonists and DPP-4 inhibitors, have been shown to offer a number of benefits over other treatments for type 2 diabetes, including reduction of… More »
This activity is supported by an educational grant from Amylin Pharmaceuticals, Inc.
Credit Type(s): CME | Credit: 0.25

CMEVIDEO
On the Scene at ADA 2012: Interview with Jack L. Leahy, MD - GLP-1 agonists as monotherapy and in combination with insulin
June 13, 2012
The incretin-based therapies, including GLP-1 receptor agonists and DPP-4 inhibitors, have been shown to offer a number of beneficial cardiovascular and lipid effects in addition to enhancing… More »
This activity is supported by an educational grant from Amylin Pharmaceuticals, Inc.
Credit Type(s): CME | Credit: 0.25

CMEVIDEO
On the Scene at ADA 2012: Interview with Michael H. Davidson, MD - Cardiovascular implications of glycemic control and therapy
June 13, 2012
The incretin-based therapies, including GLP-1 receptor agonists and DPP-4 inhibitors, have been shown to offer a number of beneficial cardiovascular and lipid effects in addition to enhancing… More »
This activity is supported by an educational grant from Amylin Pharmaceuticals, Inc.
Credit Type(s): CME | Credit: 0.25